Saffron: A Multitask Neuroprotective Agent for Retinal Degenerative Diseases

Area of Science:

• Ophthalmology
• Neuroscience
• Pharmacology

Background:

• Oxidative stress is a key factor in age-related macular degeneration (AMD) and light-induced retinal damage.
• Saffron demonstrates neuroprotective properties and has been investigated for AMD.
• Light-damaged (LD) rat models are used to study retinal degenerative diseases and test neuroprotectants.

Purpose of the Study:

• To investigate the neuroprotective effects of saffron in a light-induced retinal damage rat model.
• To compare the efficacy of saffron versus lutein/zeaxanthin in treating patients with age-related macular degeneration (AMD).

Main Methods:

• Utilized a light-damaged (LD) rat model with saffron treatment, employing SDS-PAGE, Western Blotting, enzyme activity assays, and immunolabeling.
• Conducted a longitudinal open-label study comparing saffron and lutein/zeaxanthin treatments in AMD patients over 29 months.
• Assessed visual function in patients using electroretinography (ERG) and clinical examinations.

Main Results:

• Saffron treatment reduced MMP-3 enzymatic activity and expression in LD rat retinas, preventing "rosettes" and microglia activation.
• Saffron-treated AMD patients maintained stable visual function, while the lutein/zeaxanthin group showed deterioration.
• Saffron demonstrated a potential additional mechanism of action beyond simple antioxidant effects.

Conclusions:

• Saffron exhibits complex neuroprotective activities, offering potential benefits for retinal degenerative conditions.
• Saffron supplementation may provide added value in managing age-related macular degeneration (AMD) compared to standard antioxidant treatments.
• Further research into saffron's components and mechanisms is warranted for retinal disease therapy.